17β-estradiol contributes to the accumulation of myeloid-derived suppressor cells in blood by promoting TNF-α secretion Guanjun Dong1

Acta Biochimica et Biophysica Sinica

Volumn 47, Issue 8, 2015, Pages 620-629

  You, Ming ^a   Fan, Hongye ^b   Ji, Jianjian ^a   Ding, Liang ^a   Li, Pengfei ^c   Hou, Yayi ^a,d  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d NANJING UNIVERSITY   (China)

Author keywords

CD11b+Gr 1+ cells; Estrogen; Gender difference; Myeloid derived suppressor cells; Tumor necrosis factor

Indexed keywords

ESTRADIOL; SUPPRESSOR FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; BLOOD; BONE MARROW CELL; FEMALE; IMMUNOLOGY; MALE; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; SECRETION (PROCESS); SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ESTRADIOL; FEMALE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MYELOID CELLS; SEX FACTORS; SUPPRESSOR FACTORS, IMMUNOLOGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84941559063     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmv053     Document Type: Article

References (46)

1. McClelland EE, Smith JM. Gender specific differences in the immune response to infection. Arch Immunol Ther Exp (Warsz) 2011, 59: 203-213
2. Choudhry MA, Bland KI, Chaudry IH. Trauma and immune response-effect of gender differences. Injury 2007, 38: 1382-1391
3. Straface E, Gambardella L, Brandani M, Malorni W. Sex differences at cellular level: "cells have a sex". Handb Exp Pharmacol 2012, 214: 49-65
4. Giampietri C, Petrungaro S, Filippini A, Ziparo E. Sex-related differences in death control of somatic cells. J Cell Mol Med 2013, 17: 550-551
5. Fan H, Dong G, Zhao G, Liu F, Yao G, Zhu Y, Hou Y. Gender differences of B cell signature in healthy subjects underlie disparities in incidence and course of SLE related to estrogen. J Immunol Res 2014, 2014: 814598
6. Abdullah M, Chai PS, Chong MY, Tohit ER, Ramasamy R, Pei CP, Vidyadaran S. Gender effect on in vitro lymphocyte subset levels of healthy individuals. Cell Immunol 2012, 272: 214-219
7. Sankaran-Walters S, Macal M, Grishina I, Nagy L, Goulart L, Coolidge K, Li J, et al. Sex differences matter in the gut: effect on mucosal immune activation and inflammation. Biol Sex Differ 2013, 4: 10
8. Rubtsov AV, Rubtsova K, Kappler JW, Marrack P. Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev 2010, 9: 494-498
9. Gonzalez DA, Diaz BB, Rodriguez Perez Mdel C, Hernandez AG, Chico BN, de Leon AC. Sex hormones and autoimmunity. Immunol Lett 2010, 133: 6-13
10. Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, Skakic V, et al. Women, men, and rheumatoid arthritis: Analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 2009, 11: R7
11. Masi AT, Kaslow RA. Sex effects in systemic lupus erythematosus: A clue to pathogenesis. Arthritis Rheum 1978, 21: 480-484
12. Nalbandian G, Kovats S. Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol Res 2005, 31: 91-106
13. Josefsson E, Tarkowski A, Carlsten H. Anti-inflammatory properties of estrogen. I. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils. Cell Immunol 1992, 142: 67-78
14. Xie H, Hua C, Sun L, Zhao X, Fan H, Dou H, Hou Y. 17beta-estradiol induces CD40 expression in dendritic cells via MAPK signaling pathways in a minichromosome maintenance protein 6-dependent manner. Arthritis Rheum 2011, 63: 2425-2435
15. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012, 12: 253-268
16. Ochoa AC, Zea AH, Hernandez C, Rodriguez PC. Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res 2007, 13: 721s-726s
17. Delano MJ, Scumpia PO, Weinstein JS, Coco D, Nagaraj S, Kelly-Scumpia KM, O'Malley KA, et al. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med 2007, 204: 1463-1474
18. Solito S, Falisi E, Diaz-Montero CM, Doni A, Pinton L, Rosato A, Francescato S, et al. A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood 2011, 118: 2254-2265
19. Liu CY, Wang YM, Wang CL, Feng PH, Ko HW, Liu YH, Wu YC, et al. Population alterations of L-arginase-and inducible nitric oxide synthase-expressed CD11b+/CD14(-)/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage nonsmall cell lung cancer. J Cancer Res Clin Oncol 2010, 136: 35-45
20. Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S, Bronte V. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 2010, 22: 238-244
21. Ribechini E, Greifenberg V, Sandwick S, Lutz MB. Subsets, expansion and activation of myeloid-derived suppressor cells. Med Microbiol Immunol 2010, 199: 273-281
22. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009, 9: 162-174
23. Yang L, DeBusk LM, Fukuda K, Fingleton B, Green-Jarvis B, Shyr Y, Matrisian LM, et al. Expansion of myeloid immune suppressor Gr +CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 2004, 6: 409-421
24. Haile LA, von Wasielewski R, Gamrekelashvili J, Kruger C, Bachmann O, Westendorf AM, Buer J, et al. Myeloid-derived suppressor cells in inflammatory bowel disease: A new immunoregulatory pathway. Gastroenterology 2008, 135: 871-881, 881 e871-875
25. Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009, 182: 4499-4506
26. Meyer C, Sevko A, Ramacher M, Bazhin AV, Falk CS, Osen W, Borrello I, et al. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Proc Natl Acad Sci USA 2011, 108: 17111-17116
27. Sinha P, Chornoguz O, Clements VK, Artemenko KA, Zubarev RA, Ostrand-Rosenberg S. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. Blood 2011, 117: 5381-5390
28. Van Ginderachter JA, Beschin A, De Baetselier P, Raes G. Myeloid-derived suppressor cells in parasitic infections. Eur J Immunol 2010, 40: 2976-2985
29. Zhang H, Wang S, Huang Y, Wang H, Zhao J, Gaskin F, Yang N, et al. Myeloid-derived suppressor cells are proinflammatory and regulate collagen-induced arthritis through manipulating Th17 cell differentiation. Clin Immunol 2015, 157: 175-186
30. Yi H, Guo C, Yu X, Zuo D,Wang XY. Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis. J Immunol 2012, 189: 4295-4304
31. Guo C, Hu F, Yi H, Feng Z, Li C, Shi L, Li Y, et al. Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis. Ann Rheum Dis 2014, doi: 10. 1136/annrheumdis-2014-205508
32. Trigunaite A, Khan A, Der E, Song A, Varikuti S, Jorgensen TN. Gr-1(high) CD11b+ cells suppress B cell differentiation and lupus-like disease in lupus-prone male mice. Arthritis Rheum 2013, 65: 2392-2402
33. Weckerle CE, Mangale D, Franek BS, Kelly JA, Kumabe M, James JA, Moser KL, et al. Large-scale analysis of tumor necrosis factor alpha levels in systemic lupus erythematosus. Arthritis Rheum 2012, 64: 2947-2952
34. Mak A, Tang CS, Ho RC. Serum tumour necrosis factor-alpha is associated with poor health-related quality of life and depressive symptoms in patients with systemic lupus erythematosus. Lupus 2013, 22: 254-261
35. Sade-Feldman M, Kanterman J, Ish-Shalom E, Elnekave M, Horwitz E, Baniyash M. Tumor necrosis factor-alpha blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity 2013, 38: 541-554
36. Zhao X, Rong L, Li X, Liu X, Deng J, Wu H, Xu X, et al. TNF signaling drives myeloid-derived suppressor cell accumulation. J Clin Invest 2012, 122: 4094-4104
37. Stein B, Yang MX. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol 1995, 15: 4971-4979
38. Cvoro A, Tzagarakis-Foster C, Tatomer D, Paruthiyil S, Fox MS, Leitman DC. Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression. Mol Cell 2006, 21: 555-564
39. Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007, 28: 521-574
40. Marriott I, Huet-Hudson YM. Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res 2006, 34: 177-192
41. Adrie C, Azoulay E, Francais A, Clech C, Darques L, Schwebel C, Nakache D, et al. Influence of gender on the outcome of severe sepsis: A reappraisal. Chest 2007, 132: 1786-1793
42. Breedveld F. TNF antagonists opened the way to personalized medicine in rheumatoid arthritis. Mol Med 2014, 20(Suppl 1): S7-S9
43. Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, Bui MM, Ortiz M, et al. Inhibition of dendritic cell differentiation and accumulation of myeloidderived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 2008, 205: 2235-2249
44. Friedberg J, Jacobsen E, Neuberg D, Kutok J, Munoz O, Boussiotis V, Reynolds H, et al. Targeting the follicular lymphoma microenvironment through blockade of TNFalpha with etanercept. Leuk Lymphoma 2008, 49: 902-909
45. Wilson JA. Tumor necrosis factor alpha and colitis-associated colon cancer. N Engl J Med 2008, 358: 2733-2734
46. Robinson DP, Hall OJ, Nilles TL, Bream JH, Klein SL. 17beta-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs. J Virol 2014, 88: 4711-4720